A novel 1.38-kb deletion combined with a single nucleotide variant in KIAA0586 as a cause of Joubert syndrome

doi:10.21203/rs.3.rs-2012528/v1

Download PDF

Research Article

A novel 1.38-kb deletion combined with a single nucleotide variant in KIAA0586 as a cause of Joubert syndrome

https://doi.org/10.21203/rs.3.rs-2012528/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 12 Jan, 2023

Read the published version in BMC Medical Genomics →

You are reading this latest preprint version

Background: KIAA0586, also known as Talplid3, plays critical roles in primary cilia formation and hedgehog signaling in humans. Variants in KIAA0586 could cause some different ciliopathies, including Joubert syndrome (JBTS), which is a clinically and genetically heterogeneous group of autosomal recessive neurological disorders.

Methods and Results: A 9-month-old girl was diagnosed as JBTS by the “molar tooth sign” of the mid-brain and global developmental delay. By whole-exome sequencing, we identified a single nucleotide variant c.3303G>A and a 1.38-kb deletion in KIAA0586 in the proband. These two variants of KIAA0586 were consistent with the mode of autosomal recessive inheritance in the family, which was verified using Sanger sequencing.

Conclusions: This finding of a compound heterozygote with a 1.38-kb deletion and c.3303G>A gave a precise genetic diagnosis for the patient, and the novel 1.38-kb deletion also expanded the pathogenic variation spectrum of JBTS caused by KIAA0586.

Joubert syndrome

KIAA0586

variant

genomic deletion

JBTS (JBTS, OMIM#213300) is a clinically and genetically heterogeneous group of autosomal recessive neurological disorders characterized by a distinctive mid-hindbrain malformation (“molar tooth sign” on brain imaging), hypotonia and developmental delay/intellectual disability[1–3]. KIAA0586 (also known as Talpid3) encodes a centrosomal protein that is essential for primary cilia formation and hedgehog signaling[4–6]. Variations in KIAA0586 could cause some different ciliopathies, such as one subtype of Joubert syndrome (JBTS23, OMIM #616490), preaxial polydactyly and short rib thoracic dysplasia 14 (SRTD14; OMIM #616546)[7–10]. More than 50 variations in the KIAA0586 gene were reported to be cause of JBTS in homozygous or compound heterozygous states, and the types of these variations varied, including missense/nonsense mutations, splice sites, small insertions/deletions or long-fragment genomic deletions[7, 11–17].

With whole-exome sequencing (WES), we identified a novel 1.38-kb deletion and a single nucleotide variant (SNV) in KIAA0586 in a Joubert syndrome patient and confirmed them using Sanger sequencing in the family.

Clinical summary

A 9-month-old girl was born after normal labor with a birth weight of 3.30 kg and height of 50 cm at 39 weeks gestation. Her parents were inconsanguineous. She is the second child of her family and has an elder sister. Her parents and sister are unaffected. The girl was hospitalized because of severe respiratory problems at birth, and then for delayed global development at 9 months. She can raise her head until 4 months, and can turn over until 8 months, cannot sat all by herself, and cannot stand when supporting station. She can grasp objects on her own initiative. She can identify her mother and speak with only monosyllables “mama, baba, et al.” She often stuck out her tongue unconsciously. The girl had mild retardation for language and fine movements, moderate retardation for adaptability and social abilities, and severe retardation for large motor abilities, as evaluated by the Chinese Developmental Scale for children aged 0–6 years (WS/T 580–2017). The girl was fed with milk powder. The girl had a height of 74 cm (+ 1 SD), weight of 9 kg (median ~ + 1 SD), and occipitofrontal circumference of 45 cm (+ 1 SD) at 9 months old. Physical examination showed strabismus, hypotonia and lower myodynamia. No abnormalities were mentioned for the heart, liver, gallbladder, spleen, kidneys, ureter, or bladder. Magnetic resonance imaging of her brain revealed that the superior cerebellar peduncle was thickened and lengthened (molar tooth sign), and the shape of the cerebellar vermis was irregular and partially missing (Fig. 1). There was a link near the midline of the bilateral cerebellar hemispheres. The upper part of the fourth ventricle seemed to be bat wings. Thus, the girl was diagnosed with Joubert syndrome.

Genetic investigations

A 2 mL EDTA anticoagulant venous blood sample was obtained from the proband, her parents and her elder sister. Genomic DNA was extracted from whole blood using QIAamp® DNA Blood mini Kit (QIAGEN, Germany) according to the manufacturer’s protocol. Whole-Exome Sequencing (WES) and SNVs/InDel analysis were performed for the proband as previously described[18]. Splice variants were evaluated using the online tool SpliceAI (https://spliceailookup.broadinstitute.org). Identification and annotation of genetically mobile domains and the analysis of domain architectures were performed by SMART (a Simple Modular Architecture Research Tool) (http://smart.embl-heidelberg.de/).

The WES data were further analyzed for copy number variants (CNVs). We made a virtual gene panel for JBTS and other ciliopathies using Phenolyzer[19] and OMIM (https://omim.org/) (There were a total of 169 related genes, data not shown). We obtained the chromosomal position information of exons of the classical transcripts from UCSC (https://genome.ucsc.edu/) for all candidate genes, and generated a bed file for all exons. Based on the hypothesis that exon deletion/duplication rarely occurs in JBTS, we performed CNV assessment using a read depth-based CNV detection algorithm[20]. Three WES data at the same sequencing batch, including the proband and two unaffected individuals were involved in CNV analysis. The mean depth of each exon was obtained with Samtools (https://anaconda.org/bioconda/samtools). Using Integrative Genomics Viewer (IGV, http://software.broadinstitute.org/software/igv/), the called exon deletions/duplications were confirmed manually.

SNV verification

PCR was performed using specific primer pairs for candidate SNV validation screened from WES in the proband and her family members. The Supplementary Table 1 lists the primer sequences.

CNV verification and precise breakpoint determination

To verify the CNV, we firstly carried out a relative quantitative PCR to analyze genome relative copy number of exon 15 of KIAA0586 (NM_001244189.1) in the family. Triplicate quantitative PCR for genomic DNA was performed using SYBR Green qPCR Master Mix (Life Technologies, USA) on ABI7500 (Life Technologies, USA). ALB (albumin) was used as an internal control. The delta-delta CT value analysis method was used to evaluate the relative copy number of genome KIAA0586 exon 15 for all samples. Target and internal control gene primer pairs are listed in Supplementary Table 1. Then, we performed a long PCR to determine the precise breakpoint of the deletion. The long PCR primer sequences are shown in Supplementary Table 1.

RNA extraction and reverse transcription

The Tempus™ Spin RNA Isolation Kit (Invitrogen, USA) was used for RNA extraction from whole blood cells of the proband and her parents and sister. One microgram RNA was reverse transcribed into cDNA using a SuperScript™ IV First-Strand Synthesis System Kit (Invitrogen, USA). The primer sequences for investigating the effect of deletion in the transcript are listed in Supplementary Table 1.

The PCR amplification products from the verification of SNVs and CNVs were analyzed by agarose gel electrophoresis, and then Sanger sequencing was performed on an ABI3730xl Genetic Analyzer (Life Technologies, USA) following the manufacturer's protocol.

WES revealed a splicing variant (NM_001244189.1: c.3303G > A) and a genomic region with a 1.38-kb deletion (NC_000014.9: g.58,926,242 − 58,927,621del) in KIAA0586 as causes of Joubert syndrome in a 9-month-old girl (Fig. 2). The reported splicing variant c.3303G > A (NM_001244189.1) was verified in the heterozygous state in the proband, her mother and her sister, which was validated by direct Sanger sequencing (Fig. 2b). This variant might cause aberrant splicing predicted by the online software SpliceAI, remove 56 base pairs at the end of exon 23 (NM_001244189.1) and terminate early translation (NP_001231118.1: p.Pro1084LysfsTer22), which was described in detail by Bachmann-Gagescu et al[7]. Our RNA extraction and reverse transcription experiments also confirmed this finding (data not shown). The 1.38-kb deletion led to the removal of part of intron 14, exon 15 and part of intron 15 of KIAA0586 (NM_001244189.1), causing exon 15 skipping in the transcript (Fig. 2c,d), which was predicted to be a 76 amino acid deletion (position 605 to 681) encoded by exon 15 during protein translation. Compared to the mother and the sister, results of qPCR showed that the proband and her father only had relative half-fold copy for exon 15 (Supplementary Table 2). The precise breakpoints of the deletion were at positions 58,926,242 and 58,927,621 on chromosome 14, as determined by long PCR. The Database of Genomic Variants (http://dgv.tcag.ca) and Decipher (https://decipher.sanger.ac.uk) had not previously described deletions for this genomic region. According to the ACMG guidelines, these two variants were classified as pathogenic. No additional deleterious variant of other Joubert syndrome- or ciliopathy-related genes was identified in the WES data of the proband.

We identified a novel genomic deletion (g.58,926,242 − 58,927,621del) in the KIAA0586 gene combined with a splicing variant (NM_001244189.1: c.3303G > A) as a cause for JBTS. The deletion was paternally inherited, and the c.3303G > A variant was maternally inherited. These two variants were present in the heterozygous state in the affected child, which was consistent with the autosomal recessive inheritance mode.

DNA fragments of approximately > 50 bp are defined as CNVs, which include deletions and duplications [21, 22]. In addition to SNVs or small insertions/deletions, CNVs may also be the cause of some human diseases[23, 24]. Three different long fragment genomic deletions in KIAA0586 were reported previously[13–15]. With a functional genome-wide siRNA screen, Roosing et al. found a > 15.6 kb deletion spanning exons 12 to 20 (NM_001244189.1, chr14:?_58923420_58938997_?del; c.1413-?_2793+?del) in a Turkish patient, and the breakpoints were not defined[14]. In the transcript, this deletion was predicted to lead to the removal of exons 12 to 20 in KIAA0586 (NM_001244189.1), causing direct splicing of exons 11 to 21, leading to early translational termination (p.Phe472LysfsTer49). An 8.26-kb genomic deletion that led to the removal of exons 8, 9 and 10 was reported by Malicdan et al in two Jeune and Joubert syndrome families[15]. This deletion removed a 544-bp gene fragment including exons 8, 9 and 10 in KIAA0586 (NM_001244189.1) in the transcript, and led to a frameshift and formation of a premature stop codon (p.Val249GlufsTer3) in exon 11. Sumathipala et al. reported another 8.3kb genomic deletion in KIAA0586 using WGS data[13]. The deletion also led to the removal of exons 8, 9 and 10 and then made an early termination (p.Val249GlufsTer3) in the transcript. However, these two deletions had different breakpoints, the former was in chr14 (GRCh37):g.58,910,322 − 58,918,560, and the latter in chr14 (GRCh37):g.58,910,301–58,918,610. In humans, TALPID3 domain is located at amino acids 183 to 1,411 as the critical functional domain of KIAA0586, which spans exon 6 to 30. The reported KIAA0586 long genomic deletions were all located in this domain and predicted to make truncated proteins. The other single nucleotide variants (SNVs)/indels in these affected individuals also produce premature stop codon. The novel genomic deletion (g.58,926,242 − 58,927,621del) in our study removed exon 15 in KIAA0586 (NM_001244189.1), and divided the whole TALPID3 domain into two parts (amino acids 183 to 608 and 605 to 1335), which suggested that the changed protein could perform incomplete TALPID3 functions. The other variant (c.3303G > A, p.Pro1084LysfsTer22) produced truncated protein, which may be the reason why the patient's phenotype was milder than those previously reported. Further exploration of KIAA0586 function is still necessary.

Compared to SRTD14 and other forms of Joubert syndrome, the phenotype of JBTS23 is relatively mild, and most organ systems are generally unaffected. We diagnosed the 9-month-old girl with Joubert syndrome basically for hindbrain malformation and other characteristics according to the criteria of JBTS diagnosis. The other symptoms in our patient included breathing problems, strabismus, hypotonia and lower myodynamia, but no abnormalities for other organ systems. We identified pathogenic compound heterozygous variants in KIAA0586 by WES, which was compatible with the reported genotype-phenotype for JBTS caused by KIAA0586. Thus, a genetic diagnosis of JBTS23 was given to the girl. Abnormal neurological, skeletal, and renal phenotypes are often observed in JBTS patients with KIAA0586 variants[7]. This suggests it is necessary to pay attention to the development of these systems in medical examinations for this girl.

In our study, the finding of a compound heterozygote with a 1.38-kb deletion and c.3303G > A variant gave a precise molecular diagnosis for the Joubert syndrome patient, and was helpful for the doctors and parents providing quality care to her. Meanwhile, the novel 1.38-kb deletion also expanded pathogenic variation spectrum of JBTS caused by KIAA0586. Further functional validation is still necessary for clarify of the pathogenic mechanism of the KIAA0586 gene in Joubert syndrome.

Ethics approval and consent to participate: Written informed consent was obtained from all participants(the patient’s consent was signed by the parents). This study was approved by the ethical committees of the National Research Institute for Family Planning and clearly stated that the blood samples would be used for scientific research purposes, including genetic studies. All the procedures followed were in accordance with the Helsinki Declaration.

Consent for publication: Written informed consent was obtained from the patient’s parents for publication of this report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.

Availability of data and materials: The datasets generated and/or analysed during the current study are available in the human reference 8 genome (GRCh37/hg19), NM_001244189.1.

Competing interests: The authors declare that they have no competing interests.

Funding: The work was supported by the following: National Key Research and Development Program of China (2016YFC1000307) to Xu Ma, The Non-profit Central Research Institute Fund of National Research Institute for Family Planning (2020GJZ05) to Minna Luo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Authors' contributions: YS was the major contributor in writing the manuscript. YS and ML analyzed and interpreted the patient data. CL and TC contributed to DNA extraction and sequencing experiments. ZC and CC analyzed the sequencing data. XM and HG provided useful suggestions for writing the article. All authors read and approved the final manuscript.

Acknowledgements: We were so thankful for participation of the patient family in this study.

Maria BL, Hoang KB, Tusa RJ, Mancuso AA, Hamed LM, Quisling RG, Hove MT, Fennell EB, Booth-Jones M, Ringdahl DM et al: "Joubert syndrome" revisited: key ocular motor signs with magnetic resonance imaging correlation. J Child Neurol 1997, 12(7):423–430.
Parisi MA, Doherty D, Chance PF, Glass IA: Joubert syndrome (and related disorders) (OMIM 213300). Eur J Hum Genet 2007, 15(5):511–521.
Poretti A, Snow J, Summers AC, Tekes A, Huisman T, Aygun N, Carson KA, Doherty D, Parisi MA, Toro C et al: Joubert syndrome: neuroimaging findings in 110 patients in correlation with cognitive function and genetic cause. J Med Genet 2017, 54(8):521–529.
Yin Y, Bangs F, Paton IR, Prescott A, James J, Davey MG, Whitley P, Genikhovich G, Technau U, Burt DW et al: The Talpid3 gene (KIAA0586) encodes a centrosomal protein that is essential for primary cilia formation. Development 2009, 136(4):655–664.
Bangs F, Antonio N, Thongnuek P, Welten M, Davey MG, Briscoe J, Tickle C: Generation of mice with functional inactivation of talpid3, a gene first identified in chicken. Development 2011, 138(15):3261–3272.
Nagase T, Ishikawa K, Miyajima N, Tanaka A, Kotani H, Nomura N, Ohara O: Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Res 1998, 5(1):31–39.
Bachmann-Gagescu R, Phelps IG, Dempsey JC, Sharma VA, Ishak GE, Boyle EA, Wilson M, Marques Lourenco C, Arslan M, Shendure J et al: KIAA0586 is Mutated in Joubert Syndrome. Hum Mutat 2015, 36(9):831–835.
Alby C, Piquand K, Huber C, Megarbane A, Ichkou A, Legendre M, Pelluard F, Encha-Ravazi F, Abi-Tayeh G, Bessieres B et al: Mutations in KIAA0586 Cause Lethal Ciliopathies Ranging from a Hydrolethalus Phenotype to Short-Rib Polydactyly Syndrome. Am J Hum Genet 2015, 97(2):311–318.
Cocciadiferro D, Agolini E, Digilio MC, Sinibaldi L, Castori M, Silvestri E, Dotta A, Dallapiccola B, Novelli A: The splice c.1815G > A variant in KIAA0586 results in a phenotype bridging short-rib-polydactyly and oral-facial-digital syndrome: A case report and literature review. Medicine (Baltimore) 2020, 99(8):e19169.
Wang T, Xuan Z, Dou Y, Liu Y, Fu Y, Ren J, Lu L: Identification of novel mutations in preaxial polydactyly patients through whole-exome sequencing. Mol Genet Genomic Med 2019, 7(6):e690.
Stark Z, Tan TY, Chong B, Brett GR, Yap P, Walsh M, Yeung A, Peters H, Mordaunt D, Cowie S et al: A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders. Genet Med 2016, 18(11):1090–1096.
Stephen LA, Tawamie H, Davis GM, Tebbe L, Nurnberg P, Nurnberg G, Thiele H, Thoenes M, Boltshauser E, Uebe S et al: TALPID3 controls centrosome and cell polarity and the human ortholog KIAA0586 is mutated in Joubert syndrome (JBTS23). Elife 2015, 4.
Sumathipala D, Stromme P, Gilissen C, Einarsen IH, Bjorndalen HJ, Server A, Corominas J, Hassel B, Fannemel M, Misceo D et al: Sudden death in epilepsy and ectopic neurohypophysis in Joubert syndrome 23 diagnosed using SNVs/indels and structural variants pipelines on WGS data: a case report. BMC Med Genet 2020, 21(1):96.
Roosing S, Hofree M, Kim S, Scott E, Copeland B, Romani M, Silhavy JL, Rosti RO, Schroth J, Mazza T et al: Functional genome-wide siRNA screen identifies KIAA0586 as mutated in Joubert syndrome. Elife 2015, 4:e06602.
Malicdan MC, Vilboux T, Stephen J, Maglic D, Mian L, Konzman D, Guo J, Yildirimli D, Bryant J, Fischer R et al: Mutations in human homologue of chicken talpid3 gene (KIAA0586) cause a hybrid ciliopathy with overlapping features of Jeune and Joubert syndromes. J Med Genet 2015, 52(12):830–839.
Akawi N, McRae J, Ansari M, Balasubramanian M, Blyth M, Brady AF, Clayton S, Cole T, Deshpande C, Fitzgerald TW et al: Discovery of four recessive developmental disorders using probabilistic genotype and phenotype matching among 4,125 families. Nat Genet 2015, 47(11):1363–1369.
Summers AC, Snow J, Wiggs E, Liu AG, Toro C, Poretti A, Zein WM, Brooks BP, Parisi MA, Inati S et al: Neuropsychological phenotypes of 76 individuals with Joubert syndrome evaluated at a single center. Am J Med Genet A 2017, 173(7):1796–1812.
Shen Y, Wang H, Liu Z, Luo M, Ma S, Lu C, Cao Z, Yu Y, Cai R, Chen C et al: Identification of two novel pathogenic variants of PIBF1 by whole exome sequencing in a 2-year-old boy with Joubert syndrome. BMC medical genetics 2020, 21(1):192.
Yang H, Robinson PN, Wang K: Phenolyzer: phenotype-based prioritization of candidate genes for human diseases. Nature methods 2015, 12(9):841–843.
Fromer M, Purcell SM: Using XHMM Software to Detect Copy Number Variation in Whole-Exome Sequencing Data. Current protocols in human genetics 2014, 81:7 23 21–21.
Kerkhof J, Schenkel LC, Reilly J, McRobbie S, Aref-Eshghi E, Stuart A, Rupar CA, Adams P, Hegele RA, Lin H et al: Clinical Validation of Copy Number Variant Detection from Targeted Next-Generation Sequencing Panels. The Journal of molecular diagnostics: JMD 2017, 19(6):905–920.
Kosugi S, Momozawa Y, Liu X, Terao C, Kubo M, Kamatani Y: Comprehensive evaluation of structural variation detection algorithms for whole genome sequencing. Genome biology 2019, 20(1):117.
Truty R, Paul J, Kennemer M, Lincoln SE, Olivares E, Nussbaum RL, Aradhya S: Prevalence and properties of intragenic copy-number variation in Mendelian disease genes. Genetics in medicine: official journal of the American College of Medical Genetics 2019, 21(1):114–123.
Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, Williams C, Stalker H, Hamid R, Hannig V et al: A copy number variation morbidity map of developmental delay. Nature genetics 2011, 43(9):838–846.

No competing interests reported.

Download PDF

Journal Publication

published 12 Jan, 2023

Read the published version in BMC Medical Genomics →

Editorial decision: Major revision
27 Oct, 2022
Reviews received at journal
10 Oct, 2022
Reviewers agreed at journal
30 Sep, 2022
Reviewers agreed at journal
19 Sep, 2022
Reviewers invited by journal
15 Sep, 2022
Editor assigned by journal
07 Sep, 2022
Editor invited by journal
06 Sep, 2022
Submission checks completed at journal
06 Sep, 2022
First submitted to journal
30 Aug, 2022

You are reading this latest preprint version

A novel 1.38-kb deletion combined with a single nucleotide variant in KIAA0586 as a cause of Joubert syndrome

Status:

Journal Publication

Version 1

Abstract

Figures

Introduction

Materials And Methods

Results

Discussion

Declarations

References

Additional Declarations

Supplementary Files

Status:

Journal Publication

Version 1